Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
Latest Events
Latest News
Product & Service
CPhI Worldwide, Fira Barcelona Gran Via, Spain
Booth No. 6C59, Oct. 24-26, 2023
DCAT Week, New York
Mar. 18-21, 2024
US Patent No.US11,731,998 B2 entitled METHOD OFPREPARINGFERRIC
CARBOXYMALTOSE was granted on Aug 22, 2023.
Formosalab receives TFDA approval for Eribulin Mesylate injectable 2023-02-22
TW Patent No. I784646 entitled METHOD FOR PREPARING FERRIC CARBOXYMALTOSE was granted on Nov 21, 2022. 2022-12-08
Formosa Labs’ fermentation production line was successfully inspected by US FDA in November 2022. 2022-11-15
TW Patent No. I781345 entitled Crystalline form of Baricitinib and method for preparation thereof was granted on Oct 21, 2022. 2022-11-08
Active Pharmaceutical Ingredients
Contract Development and Manufacturing Organization (CDMO)
Antibody Drug Conjugates (ADCs)
Injectable Manufacturing Services

Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.